Compare · head to head
LifeStance Health vs National Research
LifeStance Health ranks higher overall — 360 rank 80 vs 43.
National Research leads on Quality (75 vs 53) and Sentiment (63 vs 58). LifeStance Health leads on Growth (76 vs 29) and Safety (62 vs 38). The two are close on Value.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Providers & Services |
| Size | Medium | Small |
| ISIN | US53228F1012 | US6373722023 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 80 | 43 |
| Value | 33 | 37 |
| Quality | 53 | 75 |
| Growth | 76 | 29 |
| Safety | 62 | 38 |
| Sentiment | 58 | 63 |
| Quality details | ||
| Profitability | 38 | 89 |
| Cash Truth | 67 | 61 |
LifeStance Health vs Kestra Medical TechnologiesLifeStance Health vs NateraLifeStance Health vs Myriad GeneticsLifeStance Health vs Lumexa ImagingAdd a third stock →
Full analyses: LifeStance Health · National Research
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100